**Exhibit
      99.1**







**BALCHEM
      CORPORATION (AMEX: BCP)**


**Reported
      as follows (unaudited) for the quarter ended December 31,
      2005**


*($000
      Omitted Except for Net Earnings Per Share)*





*All
      per share information has been adjusted to reflect the three for two stock
      splits effected in the*


*form
      of 50% stock dividends declared on December 16, 2004 and December 15,
      2005.*





**For
                the Three Months Ended December 31,****2005**
            
            **2004**Net
                sales
            
            $
            23,126
            
            $
            17,957Gross
                profit
            
            
            6,737
            
            
            5,951Operating
                expenses
            
            
            2,875
            
            
            2,701Earnings
                from operations
            
            
            3,862
            
            
            3,250Other
                income
            
            
            57
            
            
            6Earnings
                before income tax expense
            
            
            3,919
            
            
            3,256Income
                tax expense
            
            
            1,287
            
            
            1,207Net
                earnings
            
            $
            2,632
            
            $
            2,049Basic
                net earnings per common share
            
            $
            0.23
            
            $
            0.18Diluted
                net earnings per common share
            
            $
            0.22
            
            $
            0.17





**For
                the Twelve Months Ended December 31,****2005**
            
            **2004**Net
                sales
            
            $
            83,095
            
            $
            67,406Gross
                profit
            
            
            28,680
            
            
            23,806Operating
                expenses
            
            
            11,777
            
            
            11,009Earnings
                from operations
            
            
            16,903
            
            
            12,797Other
                income (expense)
            
            
            288
            
            
            (82
            )Earnings
                before income tax expense
            
            
            17,191
            
            
            12,715Income
                tax expense
            
            
            6,237
            
            
            4,689Net
                earnings
            
            $
            10,954
            
            $
            8,026Basic
                net earnings per common share
            
            $
            0.95
            
            $
            0.71Diluted
                net earnings per common share
            
            $
            0.91
            
            $
            0.69








Balchem
              Corporation (AMEX:BCP)
            2





Record
      net sales were achieved for the quarter ended December 31, 2005 of $23.1
      million. This is an increase of 28.8%, as compared to $18.0 million for the
      comparable prior year. Net earnings for the fourth quarter were $2.6 million,
      an
      increase of $0.6 million, or 28.4% as compared with the same period last year.
      This resulted in an increase in diluted net earnings of 29.4% to $0.22 per
      share
      for the fourth quarter of 2005 versus $0.17 per share for the comparable quarter
      of the prior year.





In
      the
      fourth quarter of 2005, sales of the Encapsulated/Nutritional Products segment
      were $9.4 million in the period, an increase of 50.3% from the prior year
      comparable quarter, including $1.5 million of sales from the Loders Croklaan
      acquisition. This growth was driven principally by strength in sales of food
      ingredients for the domestic and international markets, improved
      sales  of
      human
      choline products and continued strong sales of REASHURE® our animal nutrition
      and health product targeted for dairy cows. Earnings from operations for this
      segment improved to $0.79 million in the current quarterly period as compared
      to
      $0.09 million in the comparable quarter of the prior year. The ARC Specialty
      Products segment generated earnings from operations of $2.6 million on fourth
      quarter sales of $7.3 million. Net sales were 1.4% lower than the prior year
      comparable quarter, principally a result of slowness in sales of ethylene oxide
      canisters, as our customers adjusted inventory levels down near year end.
      Earnings from operations for this segment were 9.3% lower than the prior year
      quarter, driven principally by higher raw material and energy costs. The BCP
      Ingredients segment realized record sales of $6.4 million, increasing 50.1%
      over
      the prior year comparable quarter, with continued strong sales volumes in dry
      and aqueous choline products for the poultry and swine industries. Earnings
      from
      operations for this segment improved 70.9% to $0.45 million as compared to
      $0.26
      million in the prior year comparable quarter. Earnings from this segment were
      also unfavorably impacted by higher raw material and energy costs.





Consolidated
      gross profit for the quarter ended December 31, 2005 was $6.7 million, an
      increase of 13.2% compared to $6.0 million for the prior year comparable period,
      due largely to the above noted increase in sales. Operating (Selling, R&D,
      and Administrative) expenses were $2.9 million, as compared to $2.7 million
      for
      the prior year comparable quarter, declining to approximately 12.4% of net
      sales
      from 15.0% of net sales in the comparable quarter of the prior year, as we
      continue to leverage our sales growth with our current
      infrastructure.





We
      set
      new net sales and net earnings records for the fiscal year ended December 31,
      2005, as net sales increased 23.3% to $83.1 million from $67.4 million in the
      comparable prior year period. Net earnings increased 36.5% to $11.0 million,
      or
      $.91 per diluted share, compared to net earnings of $8.0 million, or $0.69
      per
      diluted share, in the prior year comparable period.





Balance
      sheet ratios and our cash flow continue to be strong. Our December 31, 2005
      balance sheet reflects total net cash and investments of $13.0 million after
      recognition of the previously noted acquisition of certain assets of Loders
      Croklaan. In the quarter, we also bought back $1.1M of our stock, under our
      stock re-purchase program, due to low prices in the market. The company has
      no
      long-term debt and shareholder equity increased to $60.1 million.








|Balchem
            Corporation (AMEX:BCP) | 3
|------------------------------------------ | -

**Outlook**


Commenting
      on 2005, Dino A. Rossi, President and CEO of Balchem, said “We are very pleased
      with the overall growth of all segments of the business, and are especially
      pleased with the integration and the accretive results of the Loders Croklaan
      assets acquired. In the fourth quarter, we experienced unfavorable raw material
      cost increases that reduced our profitability by approximately $0.9M, largely
      due to the well publicized effect of increased natural gas and energy related
      costs. We continue to aggressively position ourselves with our supply chain
      providers to keep these costs as low as possible and have introduced price
      increases with our customers, effective January 1, 2006, to help defray these
      cost increases. New product introductions, volume improvements, continued
      manufacturing efficiencies and the ability to leverage off of our existing
      operating structure should help us achieve continuing double-digit growth in
      the
      upcoming year. We expect to build on our enhanced technology capabilities in
      the
      food, pharmaceutical, nutritional, and animal health markets, as well as seek
      out more strategic alliances, joint ventures or acquisitions for each of the
      segments to complement our growth objectives. To this point, one week ago,
      we
      closed the previously announced acquisition of Chelated Minerals Corporation
      (CMC). We are very pleased to add this new technology, product line and expanded
      customer base to our animal nutrition and health business. CMC had revenues
      of
      approximately $6.0 million in 2005, and we expect double digit growth in this
      business in 2006, leveraging off of our existing infrastructure both corporately
      and in the business sector.”





**Quarterly
      Conference Call**


A
      quarterly conference call will be conducted on Friday, February 17, 2006 at
      2:00
      PM Eastern Time (ET) to review fourth quarter 2005 results (for the period
      ending December 31, 2005). Dino A. Rossi, President and CEO, and Frank
      Fitzpatrick, Chief Financial Officer, will host the call. We invite you to
      listen to the call by dialing toll-free (877) 407-8289, or local (201) 689-8341,
      five minutes prior to the scheduled start time of the conference call. The
      conference call will be available for digital replay through February 22, 2006,
      by dialing toll-free (877) 660-6853, or local (201) 612-7415, and using account
      #298 and conference ID #191201. This press release, and its accompanying
      financial exhibits, will also be available on the company website, www.balchem.com ,
      prior
      to the conference call.





**Segment
      Information**


Balchem
      Corporation consists of three business segments: ARC Specialty Products,
      Encapsulated/Nutritional Products, and BCP Ingredients. Through ARC Specialty
      Products, Balchem provides specialty-packaged chemicals for use in healthcare
      and other industries. The Encapsulated/Nutritional Products segment provides
      proprietary microencapsulation and agglomeration solutions to a variety of
      applications in the food, pharmaceutical and human nutrition marketplaces.
      BCP
      Ingredients manufactures and supplies choline chloride and derivatives used
      primarily in the poultry and swine industries.





**Forward
      Looking Statements**


This
      release contains forward-looking statements, which reflect Balchem’s expectation
      or belief concerning future events that involve risks and uncertainties. Balchem
      can give no assurance that the expectations reflected in forward looking
      statements will prove correct and various factors could cause results to differ
      materially from Balchem’s expectations, including risks and factors identified
      in Balchem’s annual report on Form 10-K for the year ended December 31, 2004.
      Forward-looking statements are qualified in their entirety by the above
      cautionary statement. Balchem assumes no duty to update its outlook or other
      forward-looking statements as of any future date.





Contact:
      Karin McCaffery, Telephone: 845-326-5635





|Balchem
            Corporation (AMEX:BCP) | 4
|------------------------------------------ | -

**Selected
      Financial Data**


**($
      in 000’s)**




**Business
                    Segment Net Sales:**Three
                    Months Ended
                
                Twelve
                    Months EndedDecember
                    31,
                
                December
                    31,2005
                
                2004
                
                2005
                
                2004Specialty
                    Products
                
                $
                7,345
                
                $
                7,452
                
                $
                29,433
                
                $
                28,767Encap/Nutritional
                    Products
                
                
                9,368
                
                
                6,232
                
                
                32,499
                
                
                24,759BCP
                    Ingredients
                
                
                6,413
                
                
                4,273
                
                
                21,163
                
                
                13,880Total
                
                $
                23,126
                
                $
                17,957
                
                $
                83,095
                
                $
                67,406


**Business
                Segment Earnings:**Three
                Months Ended
            
            Twelve
                Months EndedDecember
                31,
            
            December
                31,


2005
            
            2004
            
            2005
            
            2004Specialty
                Products
            
            $
            2,630
            
            $
            2,898
            
            $
            11,007
            
            $
            10,693Encap/Nutritional
                Products
            
            
            786
            
            
            91
            
            
            3,217
            
            
            992BCP
                Ingredients
            
            
            446
            
            
            261
            
            
            2,679
            
            
            1,112Other
                income (expense)
            
            
            57
            
            
            6
            
            
            288
            
            
            (82
            )Earnings
                bef. income taxes
            
            $
            3,919
            
            $
            3,256
            
            $
            17,191
            
            $
            12,715







**Selected
                  Balance Sheet Items**
                
                December
                    31,
                
                December
                    31,2005
                
                2004Cash
                
                $
                12,996
                
                $
                12,734Accounts
                    Receivable
                
                
                11,363
                
                
                7,996Inventories
                
                
                8,540
                
                
                6,319Other
                    Current Assets
                
                
                2,367
                
                
                2,163Current
                    Assets
                
                
                35,266
                
                
                29,212Property,
                    Plant, & Equipment (net)
                
                
                24,400
                
                
                24,188Other
                    Assets
                
                
                15,475
                
                
                7,005Total
                    Assets
                
                $
                75,141
                
                $
                60,405Current
                    Liabilities
                
                $
                9,150
                
                $
                5,707Other
                    Long-Term Obligations
                
                
                5,058
                
                
                4,464Total
                    Liabilities
                
                
                14,208
                
                
                10,171Stockholders'
                    Equity
                
                
                60,933
                
                
                50,234Total
                    Liability and Stockholders' Equity
                
                $
                75,141
                
                $
                60,405